Health Bulletin 21/October/2023 - Video
Overview
Here are the top health stories for the day:
145 doctors convicted under PCPNDT act suspended by state medical councils: Union Health Minister Mandaviya
In the past 8 years, reported cases under the PC-PNDT act have risen from 2048 in March 2015 to 3563 in July 2023 while the convisions have also seen a substantial increase from 271 to 713, the data released by the government in the 29th meeting of the Central Supervisory Board (CSB) showed. The data also showed that licenses of 145 convicted doctors have been suspended by their respective State Medical Councils.
For more details, check out the link given below:
Indian-origin doctor in Bahrain fired over Anti-Palestine tweets
Amid the ongoing armed conflict between Palestinian militant groups led by Hamas and Israel, a 50-year-old Indian-origin doctor has recently been found to have breached civil peace and social stability due to an alleged anti-Palestine post on a social media platform.
The doctor was a specialist in internal medicine at the Royal Bahrain Hospital with clinical expertise in Diabetes Mellitus type 1 and type 2, Thyroid disorders, hypertension. The doctor's decision to vocally oppose Hamas and align himself with Israel has generated significant controversy. His social media post has faced severe backlash from netizens for offending a section of religious society.
For more details, check out the link given below:
Medical research panel says Nipah antibody present in bats: Kerala minister
The Indian Council for Medical Research (ICMR) has confirmed the presence of Nipah virus antibody in bat samples collected from Maruthonkara in the northern Kozhikode district, where the viral infection claimed the lives of two persons last month.
State Health Minister Veena George said on Thursday that the ICMR had conveyed this information to the state government via email.
“We have received an email from the ICMR in this regard. They informed us that the antibody was present in the bat samples collected,” she informed reporters.
For more details, check out the link given below:
Nipah Antibody Present In Bats, Confirms ICMR
First pill for dengue shows promise in human challenge trial
A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday.
There are currently no specific treatments for dengue, a growing disease threat, the company said ahead of presentation of the data at the American Society of Tropical Medicine and Hygiene Annual Meeting in Chicago.
For more details, check out the link given below:
Speakers
